DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Raltitrexed is an investigational drug.
There have been 36 clinical trials for Raltitrexed. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2015.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Neoplasm Metastasis, and Carcinoma. The leading clinical trial sponsors are Fudan University, National Cancer Institute (NCI), and Hospira, Inc.
There is one US patent protecting this investigational drug and nineteen international patents.
Recent Clinical Trials for Raltitrexed
|Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma||National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College||Phase 2|
|Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma||Beijing Konruns Pharmaceutical Co., Ltd.||Phase 2|
|Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia||Fudan University||Phase 2|
Top disease conditions for Raltitrexed
Top clinical trial sponsors for Raltitrexed
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Raltitrexed||Start Trial||Heat shock protein 70 (hsp-70) receptor ligands||Duke University (Durham, NC)||Start Trial|
|Raltitrexed||Start Trial||Compounds and their methods of use||Agios Pharmaceuticals, Inc. (Cambridge, MA)||Start Trial|
|Raltitrexed||Start Trial||Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same||Duquesne University of the Holy Spirit (Pittsburgh, PA)||Start Trial|
|Raltitrexed||Start Trial||Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus||Seattle Genetics, Inc. (Bothell, WA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Raltitrexed||World Intellectual Property Organization (WIPO)||2015148714||2034-03-25||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|